Magnolia Extract Solubility in Oral Care via PEG Mediator
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional oral compositions of magnolia extract face issues with undesired interactions between active ingredients and delivery vehicles, leading to reduced effectiveness and solubility, necessitating enhanced solubility and interaction of magnolia extract active ingredients with other components.
Innovation Solution
An oral composition comprising 0.05 to 10% polyethylene glycol (PEG 600) and 0.05 to 5% of active ingredients like magnolol, honokiol, and their synthetic analogues, combined with an orally acceptable carrier, to enhance solubility and delivery of these ingredients.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional delivery vehicles are used to formulate magnolia extract, then the composition can be delivered to the oral cavity, but the active ingredients interact undesirably with the delivery vehicle components, reducing effective performance
Solution Approach 1:
The patent uses polyethylene glycol (PEG) as an intermediary substance to solubilize the active ingredients of magnolia extract (magnolol and honokiol). PEG acts as a mediator between the hydrophobic active ingredients and the aqueous delivery vehicle components, preventing undesired interactions while maintaining effective delivery to the oral cavity.
Solution Approach 2:
The patent changes the physical-chemical parameters of the active ingredients by forming solvates or complexes with polyethylene glycol. This parameter change transforms the hydrophobic nature of magnolol and honokiol into a more hydrophilic state, enabling compatible interaction with aqueous delivery vehicle components without reducing effectiveness.
2Quantity of substance
If magnolia extract active ingredients are formulated in conventional oral compositions, then they can be delivered to the oral cavity, but their solubility is reduced due to interactions with delivery vehicle components
Solution Approach 1:
Polyethylene glycol serves as a solubility-enhancing intermediary that increases the quantity of magnolia extract active ingredients that can be dissolved in the aqueous delivery vehicle. This mediator allows higher concentrations of magnolol and honokiol to be formulated without precipitation or phase separation.
Solution Approach 2:
The patent creates a composite formulation where magnolia extract active ingredients are combined with polyethylene glycol to form a solubilized complex. This composite material exhibits enhanced solubility properties compared to the individual components, allowing effective concentrations to be achieved in the aqueous oral composition.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition provides a well-solubilized, safe, and effective solution against bacterial infections and inflammation in the oral cavity, inhibiting excess production of inflammatory mediators and maintaining therapeutic effects without adverse side effects.
Implementation Method 1
enhance the solubility and positive interaction of the one or more active ingredients of magnolia extract, or synthetic analogues thereof, with other components in oral compositions
Data Source
AI summary
Disclosed herein are methods of enhancing the solubility and delivery of one or more active ingredients found in magnolia extract, or a synthetic analogue thereof, in an oral composition.